Why eating seaweed might help prevent Parkinson's disease
Eating the seaweed Ecklonia cava may be able to slow down or prevent Parkinson's disease, according to a 2024 study.
Aug 23, 2024
0
3
Eating the seaweed Ecklonia cava may be able to slow down or prevent Parkinson's disease, according to a 2024 study.
Aug 23, 2024
0
3
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that is incurable. The disease is characterized by the selective degeneration of upper motor neurons in the motor cortex as well as the lower motor neurons ...
Aug 22, 2024
0
28
An enzyme called PGK1 has an unexpectedly critical role in the production of chemical energy in brain cells, according to a preclinical study led by researchers at Weill Cornell Medicine. The investigators found that boosting ...
Aug 21, 2024
0
64
Contrary to previous research, a new study of female participants finds no link between migraine and the risk of developing Parkinson's disease. The study is published in the August 21, 2024 online issue of Neurology.
Aug 21, 2024
0
0
In order to treat an underserved population of patients with a rare condition whose muscles gradually become weaker until they can no longer walk, a team of researchers across Japan have completed a clinical study to confirm ...
Aug 20, 2024
0
1
Two new studies from UC San Francisco are pointing the way toward round-the-clock personalized care for people with Parkinson's disease through an implanted device that can treat movement problems during the day and insomnia ...
Aug 19, 2024
0
58
Researchers at TAU's Faculty of Medical & Health Sciences invited the international community of machine learning researchers to participate in a contest devised to advance their study and assist neurologists: developing ...
Aug 19, 2024
0
30
A technique that uses videos and machine learning to quantify motor symptoms in early-stage Parkinson's disease could help reveal signs of the disease and other movement disorders earlier, which could lead to better treatment ...
Aug 15, 2024
0
9
Scientists at deCODE genetics, a subsidiary of AMGEN, have discovered rare sequence variants, predicted to cause a loss of function of ITSN1, that are associated with a high risk of Parkinson's disease. The findings also ...
Aug 15, 2024
0
32
The field of non-pharmacological interventions for the treatment of individuals with Parkinson's disease (PD) is reaching maturity and has the potential to substantially improve patient care in the future.
Aug 13, 2024
0
1